Results 281 to 290 of about 104,112 (336)
Some of the next articles are maybe not open access.
The American Journal of Cardiology, 1966
Abstract Propranolol was given by mouth to 9 hypertensive patients in doses of 30 mg. rising to 150 or 300 mg. a day over the course of 8 to 15 weeks. There was a modest fall in blood pressure during teatment. Symptoms were slight or absent, and no toxic effects were noted.
Peter M.S. Gillam, Brian N. C. Prichard
openaire +6 more sources
Abstract Propranolol was given by mouth to 9 hypertensive patients in doses of 30 mg. rising to 150 or 300 mg. a day over the course of 8 to 15 weeks. There was a modest fall in blood pressure during teatment. Symptoms were slight or absent, and no toxic effects were noted.
Peter M.S. Gillam, Brian N. C. Prichard
openaire +6 more sources
Journal of Plastic Surgery and Hand Surgery, 2013
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +3 more sources
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +3 more sources
2017
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Hatem A. Abdel Aziz +4 more
openaire +3 more sources
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Hatem A. Abdel Aziz +4 more
openaire +3 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
Brij B. Sethi, Sanjay Dube
openaire +3 more sources
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
Brij B. Sethi, Sanjay Dube
openaire +3 more sources
Obstetrics & Gynecology, 1978
Propranolol is a beta-adrenergic blocking drug with a wide spectrum of use and may diverse pharmacologic effects. This case report is an example of a parturient who was on a large dose of propranolol for idiopathic hypertrophic subaortic stenosis. The effects of this drug on pregnancy, labor, and above all, the fetus are discussed.
Stephen C. Schoenbaum +3 more
openaire +3 more sources
Propranolol is a beta-adrenergic blocking drug with a wide spectrum of use and may diverse pharmacologic effects. This case report is an example of a parturient who was on a large dose of propranolol for idiopathic hypertrophic subaortic stenosis. The effects of this drug on pregnancy, labor, and above all, the fetus are discussed.
Stephen C. Schoenbaum +3 more
openaire +3 more sources
Radioimmunoassay of propranolol
Analytical Chemistry, 1983A series of specific antibodies against d,I-propranolol has been developed by conjugation of the novel 5'-, 7'-, and 8'-(3-aminopropoxy)propranolol derivatives to succinylated bovine serum albumin. By preservation of an intact side chain in the antigen, significantly improved specificity to parent drug vs.
Daniel R. Knapp +2 more
openaire +3 more sources
Pharmacokinetics of propranolol
Journal of Pharmacokinetics and Biopharmaceutics, 1981The pharmacokinetics of propranolol after the administration of 40, 80, and 120 mg p.o. and 10 mg i.v. was studied in nine healthy male volunteers. Propranolol was analyzed after extraction and derivatization by gas-liquid chromatography. A multiexponential curve-stripping program was used for the pharmacokinetic analysis.
Lars Borgström +3 more
openaire +3 more sources
Journal of Pharmaceutical Sciences, 1979
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Yul Yost +2 more
openaire +3 more sources
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Yul Yost +2 more
openaire +3 more sources
Propranolol and hypertriglyceridemia
Atherosclerosis, 1973Abstract Eight subjects with elevated fasting plasma triglyceride levels and type IV hypertipoproteinemia, who received a 60 g fat meal before and after 2-week treatment with propranolol, showed an enhanced lipemic response to the meal after the treatment.
H. David Friedberg +3 more
openaire +3 more sources
The Hastings Center Report, 1992
When an anxiety-reducing drug with virtually no side effects is used to enhance performance, is that cheating? Is it drug abuse? Is it an admission of professional weakness? During a series of three performances, a trumpet player in a professional orchestra consistently plays a difficult solo passage flawlessly each time.
openaire +3 more sources
When an anxiety-reducing drug with virtually no side effects is used to enhance performance, is that cheating? Is it drug abuse? Is it an admission of professional weakness? During a series of three performances, a trumpet player in a professional orchestra consistently plays a difficult solo passage flawlessly each time.
openaire +3 more sources